Next Article in Journal
Fatigue as an Extra-Intestinal Manifestation of Celiac Disease: A Systematic Review
Next Article in Special Issue
Tissular Distribution and Metabolism of trans-ε-Viniferin after Intraperitoneal Injection in Rat
Previous Article in Journal
The Role of Fiber in the Treatment of Functional Gastrointestinal Disorders in Children
Previous Article in Special Issue
Do the Effects of Resveratrol on Thermogenic and Oxidative Capacities in IBAT and Skeletal Muscle Depend on Feeding Conditions?

Resveratrol, Metabolic Syndrome, and Gut Microbiota

Cardiovascular Research Institute, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA
INSERM U1048, Institute of Metabolic and Cardiovascular Diseases (I2MC) and University Paul Sabatier, 31432 Toulouse, France
Department of Fundamental Biology and Health Sciences, University of the Balearic Islands, 07122 Palma, Spain
Balearic Islands Health Research Institute (IdISBa), 07122 Palma, Spain
Authors to whom correspondence should be addressed.
Nutrients 2018, 10(11), 1651;
Received: 15 October 2018 / Revised: 27 October 2018 / Accepted: 29 October 2018 / Published: 3 November 2018
(This article belongs to the Special Issue Benefits of Resveratrol Supplementation)
Resveratrol is a polyphenol which has been shown to have beneficial effects on metabolic syndrome-related alterations in experimental animals, including glucose and lipid homeostasis improvement and a reduction in fat mass, blood pressure, low-grade inflammation, and oxidative stress. Clinical trials have been carried out to address its potential; however, results are still inconclusive. Even though resveratrol is partly metabolized by gut microbiota, the relevance of this “forgotten organ” had not been widely considered. However, in the past few years, data has emerged suggesting that the therapeutic potential of this compound may be due to its interaction with gut microbiota, reporting changes in bacterial composition associated with beneficial metabolic outcomes. Even though data is still scarce and for the most part observational, it is promising nevertheless, suggesting that resveratrol supplementation could be a useful tool for the treatment of metabolic syndrome and its associated conditions. View Full-Text
Keywords: resveratrol; gut microbiota; metabolic syndrome resveratrol; gut microbiota; metabolic syndrome
Show Figures

Graphical abstract

MDPI and ACS Style

Chaplin, A.; Carpéné, C.; Mercader, J. Resveratrol, Metabolic Syndrome, and Gut Microbiota. Nutrients 2018, 10, 1651.

AMA Style

Chaplin A, Carpéné C, Mercader J. Resveratrol, Metabolic Syndrome, and Gut Microbiota. Nutrients. 2018; 10(11):1651.

Chicago/Turabian Style

Chaplin, Alice, Christian Carpéné, and Josep Mercader. 2018. "Resveratrol, Metabolic Syndrome, and Gut Microbiota" Nutrients 10, no. 11: 1651.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop